Halozyme Therapeutics, Inc. is a leading biopharmaceutical technology company based in San Diego, California, specializing in innovative drug delivery solutions that enhance the efficacy of existing therapies. With a global presence across the United States, Europe, and Asia, Halozyme leverages its proprietary ENHANZE® technology to develop subcutaneous formulations for various indications, improving patient experience and compliance. The company collaborates with major pharmaceutical partners to expand its therapeutic portfolio, positioning itself as a pivotal player in the evolving landscape of biotechnology and drug administration.